BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

New rnai company

  1. truliapro
    87 Posts.
    clock Created with Sketch.
    14/09/14
    02:45
    Post #: 13971091
    https://proqr-tx.com

    ProQR Therapeutics B.V. is a biopharmaceutical firm based in The Netherlands that is developing RNA-based therapeutics for treating severe genetic disorders. The company plans to offer 6.3 million shares in a price range of $11 to $13 a share. Gross proceeds would be about $75 million at a market cap of around $252 million. The shares are expected to price on Wednesday and begin trading Thursday on the Nasdaq under the ticker symbol PRQR.
    BLT Price at posting: $1.06 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.